Table 1 The relationship between MALAT1 expression and clinicopathological feature of gastric cancer patients

Age (years)

0.071

 <65

24

3 (12.5)

21 (87.5)

 ≥65

23

8 (34.8)

15 (65.2)

Sex

0.725

 Male

32

7 (21.9)

25 (78.1)

 Female

15

4 (26.7)

11 (73.3)

Depth of tumor invasion

0.039

 T1 ~ T2

10

5 (50.0)

5 (50.0)

 T3 ~ T4

37

6 (16.2)

31 (83.8)

Lymph node metastasis

0.472

 Absent

16

5 (31.3)

11 (68.8)

 Present

31

6 (19.4)

25 (80.6)

Stage

0.505

 I, II

21

6 (28.6)

15 (71.4)

 III

26

5 (19.2)

21 (80.8)

Lauren’s classification

0.242

 Intestinal

27

9 (33.3)

18 (66.7)

 Diffuse

18

2 (11.1)

16 (88.9)

 Mixed

2

0 (0.0)

2 (100.0)

Differentiation

0.030

 Well to moderate

25

9 (36.0)

16 (64.0)

 Poorly or signet ring cell

22

2 (9.1)

20 (90.9)

Serum CEA value

>0.999

 ≤5

37

9 (24.3)

28 (75.7)

 >5

10

2 (20.0)

8 (80.0)

Serum CA19-9 value

0.614

 ≤37

41

9 (22.0)

32 (78.0)

 >37

6

2 (33.3)

4 (66.7)